ArticleInvestigational new drugs2016

Effect of CH-35, a novel anti-tumor colchicine analogue, on breast cancer cells overexpressing the βIII isotype of tubulin.

Lee-Chuan C Yeh et al.PubMed ↗Publisher ↗

No numbers read from the abstract.